CNATM - Cluster for Nucleic Acid Therapeutics Munich

Company

CNATM - Cluster for Nucleic Acid Therapeutics Munich

Research Services Munich, De 4 employees

Employees: 4

cnatm.de LinkedIn

CNATM - Cluster for Nucleic Acid Therapeutics Munich Overview

Headquarters: Munich, De
Website: cnatm.de
Industry: Research Services
Employees: 4
Funding: ,
NAICS: Scientific Research and Development Services

Research and Development in the Physical, Engineering, and Life Sciences

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Keywords

RNA Therapeutics RNA-Sequencing Biotechnology RNA-Delivery RNA-Targeting Drug development Oligonucleotids Research Nucleosids mRNA Genetherapy

About CNATM - Cluster for Nucleic Acid Therapeutics Munich

The Cluster for Nucleic Acid Therapeutics (CNATM) is one of the winners of the Cluster4Future competition organised by the German Federal Ministry of Education and Research (BMBF). CNATM brings together scientists from the leading universities of LMU and TUM, the Universities of Regensburg and Würzburg, the Helmholtz Zentrum München and 17 companies from the Munich region to research nucleic acid therapeutics for the pharmaceutical market of the future. The focus is on the translation of academic basic research into the pharmaceutical industry.